- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
naylorj
(57.18)
Submitted: 8/8/2012 5:27:06 PM :
Start Price:
$16.21
MDAS Score:
-6.30
EPS Ranking 96
Recs
dion2727
(65.48)
Submitted: 7/9/2012 3:53:20 PM :
Start Price:
$13.47
MDAS Score:
+12.11
finally mgmnt.,sales,and technical areashave their act together.
Recs
Roeshambow
(57.03)
Submitted: 11/28/2011 12:00:27 PM :
Start Price:
$9.63
MDAS Score:
+49.86
BECAUSE OF THE LAW. How can the company not rise in price?
Recs
kendyfreeman
(< 20)
Submitted: 5/17/2011 4:03:36 AM :
Start Price:
$15.55
MDAS Score:
+8.32
I worked for this company and have never seen a more unprofessional and crazy top management team. They change roles like most change underware, and have no idea how to support people into success. John Bardis is more interested in wrestling than his company or employees.
Recs
obsession1231
(41.42)
Submitted: 4/24/2009 6:28:20 PM :
Start Price:
$17.00
MDAS Score:
-88.70
Good solid company is a sector that should see heavy demand as US population ages; esp as healthcare coverage becomes to more people.
Recs
fctumbleweed
(< 20)
Submitted: 4/21/2009 8:10:31 AM :
Start Price:
$15.80
MDAS Score:
-87.35
Its Revenue Cycle Management segment currently has more than 1,000 hospital customers, and its Spend Management segment manages approximately $15 billion of supply spending by healthcare providers and has more than 1,700 hospital customers. Continues to grow and help the healthcare industy become more efficient.
Recs
investor55737790
(< 20)
Submitted: 2/27/2008 4:34:34 PM :
Start Price:
$17.76
MDAS Score:
-23.76
Hi growth based on helping healthcare systems improve revenues and decrease costs.
Recs
shirleyb123
(84.27)
Submitted: 1/7/2008 5:14:59 PM :
Start Price:
$22.75
MDAS Score:
+41.83
This company showed strong growth recently. I don't think it can match it's past performance.
Recs
Firesale
(< 20)
Submitted: 1/1/2008 2:34:53 AM :
Start Price:
$22.53
MDAS Score:
-36.69
MedAssets in an overlooked and unhyped recent IPO that has the synergy to succeed in the on-demand software sector. First, the company is poised to succeed regardless of a recession, economic slowdown, or continued bull market because its technology delivers solutions designed to improve operating margin, cash flow, and expense for hospitals and health systems from 1-10 percent. These factors increase the bottom line. Second, Its Revenue Cycle Management segment has more than 1,000 hospital customers, +125 customer base health systems, +2,500 acute care hospitals, and approximately 30,000 ancillary provider locations. Third, MedAssets 2006 revenue growth rate was 80%, which was nearly double the rate of Athena Health (ATHN) and 5 percent lower than Netsuite (N) two recent IPOs that have skyrocketed. Bottom line, it's not to late to establish a position in MDAS before the underwriters initiate coverage (typically positive) and the investing public catches on to this overlooked and unhyped stock.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 9 of 9